ACOG Parts Ways With ACIP - Scorecard - MDSpire

ACOG Parts Ways With ACIP

“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety."

  • By

  • Kathryn Wighton

  • February 27, 2026

  • 3 min

Share

Clinical Scorecard: ACOG Parts Ways With ACIP

At a Glance

CategoryDetail
ConditionImmunization Practices
Key MechanismsScientific integrity and evidence-based vaccine policy
Target PopulationPregnant patients, pediatric patients, and families
Care SettingObstetrics and Gynecology

Key Highlights

  • ACOG withdraws from ACIP due to concerns over scientific integrity.
  • Recent changes to vaccine recommendations bypassed established review processes.
  • ACOG emphasizes commitment to evidence-based immunization guidance.

Guideline-Based Recommendations

Diagnosis

  • Ensure immunization recommendations are based on rigorous scientific evidence.

Management

  • Develop and update evidence-based vaccine guidance for obstetrician-gynecologists.

Monitoring & Follow-up

  • Monitor changes in immunization schedules and their impact on public trust.

Risks

  • Potential reduction in public trust in immunizations due to recent ACIP actions.

Patient & Prescribing Data

Pregnant patients and their families

Vaccines are crucial for preventing serious diseases during pregnancy.

Clinical Best Practices

  • Maintain rigorous scientific review processes for vaccine recommendations.
  • Ensure expert input in immunization schedule modifications.

Related Resources & Content

Original Source(s)

ACOG Parts Ways With ACIP

  • by Kathryn Wighton

  • February 27, 2026

Related Content

Autism Announcement Changes Search Behavior

Online interest in leucovorin, folate products, and acetaminophen-related autism concerns increased markedly in the 2 weeks following the White House announcement.

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.